Technical Assistance for RFA-RM-10-006: Advancing Regulatory Science through Novel Research and Science-Based Technologies (U01)

Notice Number: NOT-RM-10-003

Key Dates
Release Date: March 11, 2010

Issued by
National Institutes of Health (NIH), (


About the online meeting:
A pre-submission teleconference will be conducted at which time NINDS and other NIH and FDA staff will explain the goals and objectives of the Advancing Regulatory Science through Novel Research and Science-Based Technologies initiative and answer questions regarding the application process and responsiveness issues. The meeting is open to any individual or organization intending to apply and applicants are highly encouraged to attend, but is not a prerequisite to applying.

Update: The following update relating to this announcement has been issued:

Details about joining the meeting:

Meeting Name: RFA RM-10-006 Pre-application Meeting
Summary: Pre-application Technical Assistance Meeting for Applications to: Advancing Regulatory Science through Novel Research and Science-Based Technologies (U01)
Invited By: Dan Tagle
When: 03/18/2010 11:00 1:00 PM
Time Zone: (GMT-05:00) Eastern Time (US and Canada)
Dial-In: 1-800-369-1881
Pass-Code: 48301

Pre-registration instructions for online meeting:

While participants are not required to pre-register, providing the following information will allow us to plan better the meeting and to contact more efficiently interested individuals if and when any additional information becomes available or in case of technical difficulties.

Please send the following to and to In the subject line, please write: RM-10-006 Pre-application Meeting

Please include the following within the email:

Your Name
Your Institution
Your Department Name
Email address
Up to 5 questions or topics for discussion/clarification

While we anticipate there will be an opportunity to ask questions during the meeting, we ask participants to send questions in advance so that we are sure to cover those most commonly submitted.


For questions or further information, contact:

Danilo A. Tagle, Ph.D.
Program Director, Neurogenetics
National Institute of Neurological Disorders and Stroke
Neuroscience Center, Room 2114
6001 Executive Boulevard
Bethesda, MD 20892 USA
Phone: (301) 496-5745


Kathy L. Kopnisky, Ph.D.
Associate Director for FDA Relations
Clinical Research, Policy Analysis and Coordination Program
National Institutes of Health
6705 Rockledge Drive
Suite 750 / Room 714
Bethesda, MD 20892-7985
Phone: (301) 435-3259